Promotion reinforces commitment to advancing our wholly owned gene therapy pipeline and strength of in-house manufacturing capabilities THOUSAND OAKS, Calif., March 12, 2024 /PRNewswire/ — Capsida Biotherapeutics (“Capsida”), a leading fully integrated targeted gene therapy company,…